Medical Device News Magazine

Artificial Joints: Engineers Are Involved In a £4 Mil Research Project to Investigate Ways of Developing a New Generation that Last Longer

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

February 22, 2021

Artificial Joints: Engineers are involved in a £4 million research project to investigate ways of developing a new generation of artificial joints that last longer, produce fewer side effects, and are better suited for younger patients.

The international collaboration, led by the University of Leeds and funded by the EU’s Horizon 2020 program, will focus on improved design and testing to reduce the chance that the implants develop faults and fail, or cause orthopedic complications.

More than 100,000 artificial joints are fitted every year in the UK. The devices have improved the quality of life for hundreds of thousands of people. But over the last two decades, problems have emerged with implants that have been painful, worked loose or deposited microscopic debris into the tissue surrounding the joint, causing severe inflammation.

Failure rates within ten years of an artificial joint is fitted range from a few percent to greater than 30 percent, depending on the type of device.

Engineers believe problems have arisen with some implants because of weaknesses in the way they were tested prior to being approved for use. The testing failed to evaluate real-world wear and tear.

Professor Richard Hall, from the School of Mechanical Engineering at Leeds, is the project’s principal investigator. He said: “Total hip and knee replacement is now an established technique that has been hugely successful. Implant technology can improve lives.

“But over the last 20 years, there have been high-profile problems with some implants failing or causing complications which require patients to have repeat surgery.

“In addition, surgeons are fitting new hips and knees to patients who are younger, heavier, and more active. That means the devices are under even greater stress. They also want to fit artificial joints in ankles and fingers and they have higher failure rates.

“To overcome these challenges, manufacturers need more accurate testing and better design. We are working with industrial, clinical, and academic partners to make that happen, to produce artificial joints that are fit for purpose.”

The researchers hope to use advanced computer simulation and laboratory tests that capture a more accurate picture of implants’ performance in a range of human activities including running, walking, jumping, and stumbling.

Better testing will inform design that meets the functional requirements of the implants.

In a break with previous testing methods, the researchers want to develop “in situ” analysis, so the performance of the device is monitored while it is being subject to mechanical testing. That will result in earlier identification – and rectification – of problems.

The main project partners are ETH Zurich, Uppsala University, and Lulea Technical University, both in Sweden and Imperial College London. The project will also train early career researchers for the medical devices industry.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”